Search Results 101-110 of 16818 for Fibronolytic
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. Heart failure with preserved ejection fraction (HFpEF) is a major public health problem that has no proven effective treatment.
The primary purpose of this study is to evaluate the safety, tolerability of single-ascending doses of BIIB100 in adults with amyotrophic lateral sclerosis (ALS) ...
A transient ischemic attack (TIA) is a transient episode of neurological dysfunction caused by focal brain, spinal cord, or retinal ischemia, without acute ...
Clot busters (thrombolytics or fibrinolytics). These drugs help break up any blood clots that are blocking blood flow to the heart. The earlier a ...
Drugs used in chemotherapy, such as carboplatin, cisplatin, and etoposide, work in different ways to stop the growth of tumor cells, either by killing the cells ...
Abstract ReviewerAnnual Meeting, Disorders of Coagulation or Fibrinolysis Section, American Society of Hematology. 2017. Oral Session ModeratorAnnual Meeting ...
Intravenous fibrinolysis as treatment of ischemic stroke at a medium-complexity hospital in General Villegas, province of Buenos Aires Neurología Argentina.2016 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.